HIGHBRIDGE CAPITAL MANAGEMENT LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2019$4,208,000
+98.8%
80,000
+100.0%
0.28%
+327.7%
Q1 2019$2,117,000
+3.1%
40,000
-20.0%
0.06%
+6.6%
Q4 2018$2,053,000
-23.5%
50,000
-29.2%
0.06%
-4.7%
Q3 2018$2,684,000
+455.7%
70,635
+237.5%
0.06%
+700.0%
Q3 2016$483,00020,9260.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders